Page last updated: 2024-12-08
1,3-diacetylchloramphenicol
Description
1,3-Diacetylchloramphenicol is a **derivative of the antibiotic chloramphenicol**. It's not a commonly used antibiotic itself, but it holds significance in research for several reasons:
**1. Potential Therapeutic Applications:**
* **Antimicrobial activity:** While not as widely used as chloramphenicol, 1,3-diacetylchloramphenicol retains some antimicrobial activity. Research investigates its potential against specific bacteria and its possible role in combination therapies.
* **Pro-drug potential:** The diacetyl groups might act as pro-drug moieties, meaning they could be inactive when administered but converted into the active chloramphenicol within the body. This could potentially overcome some of the limitations of chloramphenicol, such as its poor oral bioavailability.
**2. Research Tool:**
* **Synthesis and Chemical Modification Studies:** 1,3-diacetylchloramphenicol serves as a model compound for studying chemical modifications of chloramphenicol. Researchers might use it to develop new analogs with improved properties like increased potency, reduced toxicity, or extended half-life.
* **Structure-Activity Relationship Studies:** By comparing the activity of 1,3-diacetylchloramphenicol with other chloramphenicol derivatives, researchers can gain insights into the structural features responsible for its biological activity.
**3. Historical Importance:**
* **Chloramphenicol History:** The discovery and study of 1,3-diacetylchloramphenicol have been important in understanding the metabolism and pharmacokinetics of chloramphenicol itself. It was a significant step in the development of chloramphenicol as an antibiotic.
**Important Note:** 1,3-Diacetylchloramphenicol, like chloramphenicol, is a potent drug with potential side effects. Its use in clinical settings is very limited. Research focuses on understanding its potential benefits and risks, with the ultimate goal of developing safer and more effective therapeutic agents.
1,3-diacetylchloramphenicol: RN given refers to (R-(R*,R*))-isomer; RN for cpd without isomeric designation not avail 10/92; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (9)
Synonym |
acetamide,n-[(1r,2r)-2-(acetyloxy)-1-[(acetyloxy)methyl]-2-(4-nitrophenyl)ethyl]-2,2-dichloro- |
1,3-diacetylchloramphenicol |
10318-17-9 |
[(2r,3r)-3-acetyloxy-2-[(2,2-dichloroacetyl)amino]-3-(4-nitrophenyl)propyl] acetate |
acetamide, n-(2-(acetyloxy)-1-((acetyloxy)methyl)-2-(4-nitrophenyl)ethyl)-2,2-dichloro-, (r-(r*,r*))- |
1,3-dacp |
DTXSID80145685 |
(1r,2r)-3-acetoxy-2-[(dichloroacetyl)amino]-1-(4-nitrophenyl)propyl acetate |
CHEMBL4168656 |
Bioassays (5)
Assay ID | Title | Year | Journal | Article |
AID1355415 | Antimycobacterial activity against Mycobacterium intracellulare ATCC 23068 after 70 to 74 hrs by Alamar blue based CLSI method | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6
| Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics. |
AID1355413 | Antimicrobial activity against Pseudomonas aeruginosa ATCC 2108 at 200 ug/ml by Alamar blue based CLSI method | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6
| Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics. |
AID1355416 | Antimycobacterial activity against Mycobacterium tuberculosis ATCC 25177 after 5 days by Alamar blue based CLSI method | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6
| Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics. |
AID1355411 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 1708 at 200 ug/ml by Alamar blue based CLSI method | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6
| Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics. |
AID1355412 | Antimicrobial activity against Escherichia coli ATCC 2452 at 200 ug/ml by Alamar blue based CLSI method | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6
| Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.53
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.53 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.32 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |